Longitudinal associations of flare and damage accrual in patients with systemic lupus erythematosus.

IF 3.7 2区 医学 Q1 RHEUMATOLOGY
Rangi Kandane-Rathnayake, Dominique Milea, Worawit Louthrenoo, Alberta Hoi, Vera Golder, Jiacai Cho, Aisha Lateef, Shue-Fen Luo, Yeong-Jian Jan Wu, Laniyati Hamijoyo, Sargunan Sockalingam, Zhanguo Li, Sandra Navarra, Leonid Zamora, Masayoshi Harigai, Yasuhiro Katsumata, Madelynn Chan, Yanjie Hao, Zhuoli Zhang, Sean O'Neill, Fiona Goldblatt, Shereen Oon, Xiaomeng Xu, Aldo A Navarro Rojas, Sang-Cheol Bae, Chak Sing Lau, Mandana Nikpour, Eric Morand
{"title":"Longitudinal associations of flare and damage accrual in patients with systemic lupus erythematosus.","authors":"Rangi Kandane-Rathnayake, Dominique Milea, Worawit Louthrenoo, Alberta Hoi, Vera Golder, Jiacai Cho, Aisha Lateef, Shue-Fen Luo, Yeong-Jian Jan Wu, Laniyati Hamijoyo, Sargunan Sockalingam, Zhanguo Li, Sandra Navarra, Leonid Zamora, Masayoshi Harigai, Yasuhiro Katsumata, Madelynn Chan, Yanjie Hao, Zhuoli Zhang, Sean O'Neill, Fiona Goldblatt, Shereen Oon, Xiaomeng Xu, Aldo A Navarro Rojas, Sang-Cheol Bae, Chak Sing Lau, Mandana Nikpour, Eric Morand","doi":"10.1136/lupus-2024-001363","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To estimate the prevalence of organ damage (damage) and flare and to examine longitudinal associations between flares and subsequent damage accrual, in patients with systemic lupus erythematosus (SLE).</p><p><strong>Methods: </strong>Patients enrolled in the Asia Pacific Lupus Collaboration cohort with ≥3 years of prospectively captured data were studied. Flares were assessed at routine visits, while damage ((Systemic Lupus International Collaborating Clinics/American College of Rheumatology) Damage Index) was assessed annually. Multivariable, multifailure survival analyses were carried out to quantify the association between flares and damage accrual.</p><p><strong>Results: </strong>1556 patients with SLE with a median (IQR) of 5.7 (3.9, 7.0) years of follow-up were studied. 39.5% (n=614) of patients had damage at enrolment, and 31.9% (n=496) accrued damage during the study observation period. The incidence of damage accrual during observation was ~58/1000 person-years. Overall, 74.1% (n=1153) of patients experienced a flare of any severity (mild/moderate or severe) at least once; 56.9% (n=885) experienced recurrent (≥2) flares. The risk of subsequent damage accrual in patients who experienced mild-to-moderate flare, after controlling for confounders, was 32% greater than in patients without flares (adjusted HR) (95% CI 1.32 (1.17 to 1.72)). The risk of damage accrual was greater if patients had severe flares (HR (95% CI) 1.58 (1.18 to 2.11)). For each additional flare, the risk of damage accrual increased by 7% (HR (95% CI) 1.07 (1.02 to 1.13)).</p><p><strong>Conclusions: </strong>Flares independently increased the risk of damage accrual. Prevention of flares should be considered a necessary goal of SLE disease management to minimise permanent damage.</p>","PeriodicalId":18126,"journal":{"name":"Lupus Science & Medicine","volume":"12 1","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11751792/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lupus Science & Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/lupus-2024-001363","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To estimate the prevalence of organ damage (damage) and flare and to examine longitudinal associations between flares and subsequent damage accrual, in patients with systemic lupus erythematosus (SLE).

Methods: Patients enrolled in the Asia Pacific Lupus Collaboration cohort with ≥3 years of prospectively captured data were studied. Flares were assessed at routine visits, while damage ((Systemic Lupus International Collaborating Clinics/American College of Rheumatology) Damage Index) was assessed annually. Multivariable, multifailure survival analyses were carried out to quantify the association between flares and damage accrual.

Results: 1556 patients with SLE with a median (IQR) of 5.7 (3.9, 7.0) years of follow-up were studied. 39.5% (n=614) of patients had damage at enrolment, and 31.9% (n=496) accrued damage during the study observation period. The incidence of damage accrual during observation was ~58/1000 person-years. Overall, 74.1% (n=1153) of patients experienced a flare of any severity (mild/moderate or severe) at least once; 56.9% (n=885) experienced recurrent (≥2) flares. The risk of subsequent damage accrual in patients who experienced mild-to-moderate flare, after controlling for confounders, was 32% greater than in patients without flares (adjusted HR) (95% CI 1.32 (1.17 to 1.72)). The risk of damage accrual was greater if patients had severe flares (HR (95% CI) 1.58 (1.18 to 2.11)). For each additional flare, the risk of damage accrual increased by 7% (HR (95% CI) 1.07 (1.02 to 1.13)).

Conclusions: Flares independently increased the risk of damage accrual. Prevention of flares should be considered a necessary goal of SLE disease management to minimise permanent damage.

系统性红斑狼疮患者的耀斑和损伤累积的纵向关联。
目的:评估系统性红斑狼疮(SLE)患者器官损伤(损伤)和耀斑的患病率,并研究耀斑与随后累积的损伤之间的纵向关联。方法:入选亚太狼疮合作研究(Asia Pacific Lupus Collaboration)的患者,前瞻性数据采集≥3年。在常规就诊时评估耀斑,而每年评估损伤(系统性狼疮国际合作诊所/美国风湿病学会)损伤指数。进行了多变量、多故障生存分析,以量化耀斑与累积损伤之间的关系。结果:研究了1556例SLE患者,中位(IQR)为5.7(3.9,7.0)年随访。39.5% (n=614)的患者在入组时出现损伤,31.9% (n=496)的患者在研究观察期间出现损伤。观察期间累积损伤发生率约为58/1000人年。总体而言,74.1% (n=1153)的患者至少经历过一次任何严重程度(轻度/中度或重度)的发作;56.9% (n=885)复发(≥2次)耀斑。在控制混杂因素后,经历轻度至中度耀斑的患者发生后续损害的风险比没有耀斑的患者高32%(调整HR) (95% CI 1.32(1.17至1.72))。如果患者有严重的耀斑,累积损伤的风险更大(HR (95% CI) 1.58(1.18 ~ 2.11))。每增加一次耀斑,累积损伤风险增加7% (HR (95% CI) 1.07(1.02 ~ 1.13))。结论:照明弹单独增加了累积损伤的风险。预防耀斑应被视为SLE疾病管理的必要目标,以尽量减少永久性损害。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Lupus Science & Medicine
Lupus Science & Medicine RHEUMATOLOGY-
CiteScore
5.30
自引率
7.70%
发文量
88
审稿时长
15 weeks
期刊介绍: Lupus Science & Medicine is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific open access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus. The journal publishes research on lupus from fields including, but not limited to: rheumatology, dermatology, nephrology, immunology, pediatrics, cardiology, hepatology, pulmonology, obstetrics and gynecology, and psychiatry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信